Checkpoint inhibitor-induced autoimmune encephalitis reversed by rituximab after allogeneic bone marrow transplant in a patient with Hodgkin lymphoma

Rohit Thummalapalli, Laura A. Sena, John C. Probasco, Douglas E. Gladstone

Research output: Contribution to journalLetter

Original languageEnglish (US)
JournalLeukemia and Lymphoma
DOIs
StateAccepted/In press - Jan 1 2019

Fingerprint

Hodgkin Disease
Bone Marrow
Transplants
Rituximab
Hashimoto's encephalitis

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this

@article{f59419900f924d42bd323fa05c2bddb3,
title = "Checkpoint inhibitor-induced autoimmune encephalitis reversed by rituximab after allogeneic bone marrow transplant in a patient with Hodgkin lymphoma",
author = "Rohit Thummalapalli and Sena, {Laura A.} and Probasco, {John C.} and Gladstone, {Douglas E.}",
year = "2019",
month = "1",
day = "1",
doi = "10.1080/10428194.2019.1658104",
language = "English (US)",
journal = "Leukemia and Lymphoma",
issn = "1042-8194",
publisher = "Informa Healthcare",

}

TY - JOUR

T1 - Checkpoint inhibitor-induced autoimmune encephalitis reversed by rituximab after allogeneic bone marrow transplant in a patient with Hodgkin lymphoma

AU - Thummalapalli, Rohit

AU - Sena, Laura A.

AU - Probasco, John C.

AU - Gladstone, Douglas E.

PY - 2019/1/1

Y1 - 2019/1/1

UR - http://www.scopus.com/inward/record.url?scp=85073773362&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85073773362&partnerID=8YFLogxK

U2 - 10.1080/10428194.2019.1658104

DO - 10.1080/10428194.2019.1658104

M3 - Letter

C2 - 31502489

AN - SCOPUS:85073773362

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

SN - 1042-8194

ER -